NOTE: Deadlines will vary by individual calls; please reach out to RIS as soon as possible with your call information to determine its RIS deadline. As Horizon Europe applications typically require more institutional input than Tri-Agency applications, please reach out to RIS and your academic unit as soon as possible during the development process. Researchers… Read more »
The Mitacs – Horizon Europe IMA is designed to support Canadian faculty and eligible small and medium enterprises (SMEs) in consortium-building and proposal development under Horizon Europe Pillar II. This offering will provide short-term funding to facilitate travel and in-person engagement with European collaborators – addressing a well-recognized barrier to meaningful participation in one of… Read more »
“RIS will be offering support with application development for this opportunity. Prospective applicants are encouraged to contact Jennifer Stevens (v5js@mun.ca) or Amanda Crompton (ajcrompt@mun.ca) early during the development process to discuss the services available to them.” Description: The aim is to provide support for a small group of two to four Principal Investigators to jointly address ambitious… Read more »
Horizon Europe is the world’s largest research and innovation funding program involving countries around the globe. As one of the most ambitious funding programs, it gives Canadians access to even more opportunities to elevate their research and innovations through global partnerships. Through Horizon Europe, Canada’s talented research and innovation communities can help develop solutions to… Read more »
Horizon Europe is the world’s largest research and innovation funding program involving countries around the globe. As one of the most ambitious funding programs, it gives Canadians access to even more opportunities to elevate their research and innovations through global partnerships. Through Horizon Europe, Canada’s talented research and innovation communities can help develop solutions to… Read more »
ExpectedOutcome: Actions under this topic must contribute to all the following outcomes, ultimately contributing to reducing the burden of heart disease: – Healthcare systems and patients benefit from the development of integrated solutions for improving critical aspects in the overall care pathway (primary, ambulatory and hospital care) for heart disease. – Healthcare systems and patients… Read more »
Actions under this topic must contribute to all the following expected outcomes: Access for healthcare professionals to novel, robust and fit for purpose biomarkers with linked technologies enabling their use in clinical setting and progress towards validation. Biomarkers and linked technologies may be for diagnosis, monitoring disease progression, selecting the optimal therapeutic treatments, or assessing treatment… Read more »
The main outcome of this research collaboration is to better understand why significant advances in technology in recent years have not contributed to widespread improvements in healthcare systems, which still struggle to keep more than 50 % of people on chronic disease treatment for longer than 12 months. The goal is to develop and pilot… Read more »
The main outcome of this research collaboration is to better understand why significant advances in technology in recent years have not contributed to widespread improvements in healthcare systems, which still struggle to keep more than 50 % of people on chronic disease treatment for longer than 12 months. The goal is to develop and pilot… Read more »
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 5 “Unlocking the full potential of new tools, technologies and digital solutions for a healthy society”. To that end, proposals under this topic should aim for delivering results that are directed towards and contributing to several… Read more »